Study ID | Selection (max 4 stars) | Comparability (max 2 stars) | Outcome (max 3 stars) |
|---|
Ardeljan (2021) | **** | * | ** |
Hill, TKA (2021) | **** | -- | ** |
Hill, THA (2012) | **** | -- | ** |
Jörgensen (2013) | *** | -- | ** |
Levinger (2017) | **** | -- | ** |
- Selection
- 1) Representativeness of intervention cohort– (a) truly representative of average TKA/THA patient *; (b) somewhat representative of average TKA/THA patient*; (c) only selected group of patients; no description of derivation of cohort
- 2) Selection of non-intervention cohort—a) drawn from same community as intervention cohort*; b) drawn from different source; c) no description of the derivation of the non-intervention cohort
- 3) Ascertainment of intervention—a) health record*; b) structured interview*, c) written self-report; d) no description
- 4) Demonstration that outcome was not present of start of study—a) yes*; b) no
- Comparability
- 1) Comparability of cohorts on basis of design or analysis—a) study controls for age, sex or comorbidities*, b) study controls for any additional factors*
- Outcome
- 1) Assessment of outcome—a) independent blind assessment*; b) record linkage*; c) self-report; d) no description
- 2) Was follow up long enough for outcomes to occur—a) yes*; b) no
- 3) Adequacy of follow up cohort—a) complete follow up*; b) minimal loss to follow up (≤20%); c) follow up rate < 80% and no description of losses to follow up; d) no statement
